Cholstyq 0,5 mg, 2,5 mg Solution for injection
PDF Leaflet Revision Date: 10 May 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Reversal of residual non-depolarising neuromuscular block.
Dosage (summary)
Adults: 1-2 ml IV over 10-30 seconds; repeat if needed. Total doses >2 ml not recommended.
Onset of Action / Duration
Onset: 1 min, Duration: Not specified.
Special Populations
- Elderly
- Renal impairment
- Asthma
- Cardiac conditions
- Epilepsy
- Myasthenia gravis
Pregnancy & Breastfeeding
Caution in pregnancy; may induce uterine irritability. Monitor breastfeeding infants.
Key Drug Interactions
- Suxamethonium
- MAOIs
- Aminoglycosides
- Beta-blockers
- Antidysrhythmics
Contraindications
- Hypersensitivity to active substances
- Mechanical obstruction of GI or urinary tracts
- Concomitant use with depolarising muscle relaxants
Common side effects
- Bradycardia
- Dizziness
- Dry mouth
- Nausea
- Blurred vision
Counselling Points
- Monitor for signs of overdose
- Avoid driving if vision is affected
- Report any severe allergic reactions
Serious warnings
- Caution in patients with asthma or severe bradycardia
- Risk of cholinergic crisis in myasthenia gravis
- Potential for ventricular dysrhythmias during inhalation anaesthesia
Important Disclaimer
The Cholstyq 0,5 mg, 2,5 mg Solution for injection professional information leaflet below is the property of Umsebe Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
